HUP0102617A3 - Derivatives of pneumococcal choline binding proteins for vaccines - Google Patents

Derivatives of pneumococcal choline binding proteins for vaccines

Info

Publication number
HUP0102617A3
HUP0102617A3 HU0102617A HUP0102617A HUP0102617A3 HU P0102617 A3 HUP0102617 A3 HU P0102617A3 HU 0102617 A HU0102617 A HU 0102617A HU P0102617 A HUP0102617 A HU P0102617A HU P0102617 A3 HUP0102617 A3 HU P0102617A3
Authority
HU
Hungary
Prior art keywords
vaccines
derivatives
binding proteins
choline binding
pneumococcal choline
Prior art date
Application number
HU0102617A
Other languages
English (en)
Original Assignee
Medimmune Inc Gaithersburg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medimmune Inc Gaithersburg filed Critical Medimmune Inc Gaithersburg
Publication of HUP0102617A2 publication Critical patent/HUP0102617A2/hu
Publication of HUP0102617A3 publication Critical patent/HUP0102617A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
HU0102617A 1998-04-07 1999-04-06 Derivatives of pneumococcal choline binding proteins for vaccines HUP0102617A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8087898P 1998-04-07 1998-04-07
US8574398P 1998-05-15 1998-05-15
PCT/US1999/007680 WO1999051266A2 (en) 1998-04-07 1999-04-06 Derivatives of pneumococcal choline binding proteins for vaccines

Publications (2)

Publication Number Publication Date
HUP0102617A2 HUP0102617A2 (hu) 2001-11-28
HUP0102617A3 true HUP0102617A3 (en) 2006-04-28

Family

ID=26764078

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0102617A HUP0102617A3 (en) 1998-04-07 1999-04-06 Derivatives of pneumococcal choline binding proteins for vaccines

Country Status (16)

Country Link
US (3) US6503511B1 (hu)
EP (1) EP1067962B1 (hu)
JP (1) JP2002510649A (hu)
KR (2) KR100794394B1 (hu)
CN (1) CN1200731C (hu)
AT (1) ATE461709T1 (hu)
AU (1) AU766455C (hu)
BR (1) BR9909483A (hu)
CA (1) CA2325340A1 (hu)
DE (1) DE69942176D1 (hu)
ES (1) ES2343492T3 (hu)
HU (1) HUP0102617A3 (hu)
IL (2) IL138798A0 (hu)
NO (1) NO20004972L (hu)
NZ (2) NZ530277A (hu)
WO (1) WO1999051266A2 (hu)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7078042B2 (en) * 1995-09-15 2006-07-18 Uab Research Foundation Pneumococcal surface protein C (PspC), epitopic regions and strain selection thereof, and uses therefor
ATE461709T1 (de) * 1998-04-07 2010-04-15 Medimmune Llc Choline-bindende proteine derivate aus pneumokoken als impfstoff
US6858706B2 (en) * 1998-04-07 2005-02-22 St. Jude Children's Research Hospital Polypeptide comprising the amino acid of an N-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof
PL193132B1 (pl) * 1998-04-07 2007-01-31 Medimmune Wyizolowane polipeptydy, kompozycje farmaceutyczne, zastosowanie kompozycji farmaceutycznych, szczepionki obejmujące polipeptyd, wyizolowane cząsteczki kwasu nukleinowego, wektory, układy gospodarz-wektor, komórka, która nie jest komórką ludzką, sposoby wytwarzania polipeptydu, szczepionka obejmująca cząsteczkę izolowanego kwasu nukleinowego, zastosowania szczepionek
US7128918B1 (en) * 1998-12-23 2006-10-31 Id Biomedical Corporation Streptococcus antigens
JP2002540074A (ja) 1999-03-19 2002-11-26 スミスクライン ビーチャム バイオロジカルズ ソシエテ アノニム ワクチン
GB9918319D0 (en) 1999-08-03 1999-10-06 Smithkline Beecham Biolog Vaccine composition
AU2001287645A1 (en) * 2000-07-20 2002-02-05 Hansa Medical Ab Fh-binding protein of streptococcus pneumiae
GB0022742D0 (en) 2000-09-15 2000-11-01 Smithkline Beecham Biolog Vaccine
US6674504B1 (en) 2000-09-29 2004-01-06 Kent Optronics, Inc. Single layer multi-state ultra-fast cholesteric liquid crystal device and the fabrication methods thereof
NZ574530A (en) 2002-08-02 2010-12-24 Glaxosmithkline Biolog Sa Vaccine compositions comprising L2 and/or L3 immunotype lipooligosaccharides from lgtB-neisseria minigitidis
SI1556477T1 (sl) 2002-11-01 2017-12-29 Glaxosmithkline Biologicals S.A. Sušilni postopek
AU2004277342B2 (en) 2003-10-02 2010-12-16 Glaxosmithkline Biologicals S.A. Pertussis antigens and use thereof in vaccination
GB0505996D0 (en) 2005-03-23 2005-04-27 Glaxosmithkline Biolog Sa Fermentation process
US8052971B2 (en) * 2005-11-21 2011-11-08 MG Biologics Oral use of specific antibodies for intestinal health
TWI457133B (zh) 2005-12-13 2014-10-21 Glaxosmithkline Biolog Sa 新穎組合物
GB0607088D0 (en) 2006-04-07 2006-05-17 Glaxosmithkline Biolog Sa Vaccine
MY148141A (en) 2005-12-22 2013-03-15 Glaxosmithkline Biolog Sa Vaccine
NZ569417A (en) 2006-01-17 2012-04-27 Arne Forsgren A novel surface exposed haemophilus influenzae protein (protein E; pE)
WO2008039838A2 (en) * 2006-09-27 2008-04-03 St. Jude Children's Research Hospital Synthetic streptococcus pneumoniae vaccine
EP2167120A2 (en) 2007-06-26 2010-03-31 GlaxoSmithKline Biologicals S.A. Vaccine comprising streptococcus pneumoniae capsular polysaccharide conjugates
JP5056490B2 (ja) * 2008-03-10 2012-10-24 富士通株式会社 歪み補償係数更新装置および歪み補償増幅器
ES2553113T3 (es) 2008-04-16 2015-12-04 Glaxosmithkline Biologicals S.A. Vacuna
GB201003924D0 (en) 2010-03-09 2010-04-21 Glaxosmithkline Biolog Sa Immunogenic composition
EP2544712A1 (en) 2010-03-10 2013-01-16 GlaxoSmithKline Biologicals S.A. Immunogenic composition
GB201015132D0 (en) 2010-09-10 2010-10-27 Univ Bristol Vaccine composition
WO2012139137A2 (en) 2011-04-08 2012-10-11 Tufts Medical Center, Inc. Pepducin design and use
US20140072622A1 (en) 2011-05-17 2014-03-13 Glaxosmithkline Biologicals S.A. Vaccine against streptococcus pneumoniae
JP2014000016A (ja) * 2012-06-15 2014-01-09 National Agriculture & Food Research Organization 豚丹毒菌の新規な抗原タンパク質、その遺伝子、及び組換えベクターとその利用
GB201318170D0 (en) * 2013-10-14 2013-11-27 Univ Edinburgh Proteins with Diagnostic and Therapeutic Uses
GB201518684D0 (en) 2015-10-21 2015-12-02 Glaxosmithkline Biolog Sa Vaccine
AU2016354478B2 (en) 2015-11-13 2021-07-22 Oasis Pharmaceuticals, LLC Protease-activated receptor-2 modulators
BR112019026192B1 (pt) 2017-06-10 2022-05-10 Inventprise, Llc Vacinas de conjugado multivalente com polissacarídeos de conjugado bivalente ou multivalente que fornecem imunogenicidade e avidez melhoradas
US10729763B2 (en) 2017-06-10 2020-08-04 Inventprise, Llc Mixtures of polysaccharide-protein pegylated compounds
GB201714478D0 (en) * 2017-09-08 2017-10-25 Univ Bristol Sensor

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6027734A (en) * 1991-02-15 2000-02-22 Uab Research Foundation Mucosal administration of pneumococcal antigens
US5980909A (en) * 1991-02-15 1999-11-09 Uab Research Foundation Epitopic regions of pneumococcal surface protein A
US6042838A (en) * 1991-02-15 2000-03-28 Uab Research Foundation immunogenic compositions for mucosal administration of pneumococcal surface protein A (PspA)
US6592876B1 (en) * 1993-04-20 2003-07-15 Uab Research Foundation Pneumococcal genes, portions thereof, expression products therefrom, and uses of such genes, portions and products
US6232116B1 (en) * 1991-02-15 2001-05-15 University Of Alabama At Birmingham Research Foundation Oral administration of pneumococcal antigens
US6231870B1 (en) * 1995-06-02 2001-05-15 Uab Research Foundation Oral administration of pneumoccal antigens
US7078042B2 (en) * 1995-09-15 2006-07-18 Uab Research Foundation Pneumococcal surface protein C (PspC), epitopic regions and strain selection thereof, and uses therefor
AU732520B2 (en) * 1996-05-01 2001-04-26 Rockefeller University, The Choline binding proteins for anti-pneumococcal vaccines
US6245335B1 (en) * 1996-05-01 2001-06-12 The Rockefeller University Choline binding proteins for anti-pneumococcal vaccines
DE69739981D1 (de) * 1996-10-31 2010-10-14 Human Genome Sciences Inc Streptococcus pneumoniae-Antigene und Impfstoffe
NZ335864A (en) * 1996-11-06 2001-09-28 Univ California Isolated tumor necrosis factor receptor releasing enzyme (TRRE), compositions comprising the enzyme and methods of the use in modulation of TNF levels
JP2002503087A (ja) * 1996-11-12 2002-01-29 リージェンツ オブ ザ ユニバーシティ オブ ミネソタ ストレプトコッカス・ニューモニアのｃ３結合タンパク質
DE19708537A1 (de) 1997-03-03 1998-09-10 Biotechnolog Forschung Gmbh Neues Oberflächenprotein (SpsA-Protein) von Streptococcus pneumoniae etc.
US7018637B2 (en) * 1998-02-23 2006-03-28 Aventis Pasteur, Inc Multi-oligosaccharide glycoconjugate bacterial meningitis vaccines
US6858706B2 (en) * 1998-04-07 2005-02-22 St. Jude Children's Research Hospital Polypeptide comprising the amino acid of an N-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof
ATE461709T1 (de) * 1998-04-07 2010-04-15 Medimmune Llc Choline-bindende proteine derivate aus pneumokoken als impfstoff
US6936252B2 (en) * 1998-07-27 2005-08-30 Microbial Technics Limited Streptococcus pneumoniae proteins and nucleic acid molecules
ES2322306T3 (es) * 1998-12-21 2009-06-18 Medimmune, Inc. Proteinas de streptpcpccus pneumoniae y fragmentos inmunogenicos para vacunas.
CA2407455A1 (en) * 2000-04-27 2001-11-01 Medimmune, Inc. Immunogenic pneumococcal protein and vaccine compositions thereof
EP2921924B1 (de) * 2014-03-21 2018-09-19 Asco Numatics GmbH Vorrichtung zur Bereitstellung eines Fluids mit geregeltem Ausgangsdruck
US9741151B2 (en) * 2015-04-14 2017-08-22 International Business Machines Corporation Mobile interactive comparison chart

Also Published As

Publication number Publication date
KR20010034752A (ko) 2001-04-25
DE69942176D1 (de) 2010-05-06
CN1315870A (zh) 2001-10-03
IL138798A0 (en) 2001-10-31
AU766455B2 (en) 2003-10-16
KR20060126844A (ko) 2006-12-08
JP2002510649A (ja) 2002-04-09
AU766455C (en) 2004-12-02
NZ530277A (en) 2005-08-26
WO1999051266A2 (en) 1999-10-14
US20030138447A1 (en) 2003-07-24
IL138798A (en) 2008-11-03
US20050142145A1 (en) 2005-06-30
US6503511B1 (en) 2003-01-07
NZ507717A (en) 2004-02-27
US7435421B2 (en) 2008-10-14
CA2325340A1 (en) 1999-10-14
BR9909483A (pt) 2001-10-09
NO20004972D0 (no) 2000-10-03
KR100794394B1 (ko) 2008-01-15
US6863893B2 (en) 2005-03-08
AU3386999A (en) 1999-10-25
ES2343492T3 (es) 2010-08-02
CN1200731C (zh) 2005-05-11
NO20004972L (no) 2000-12-05
EP1067962B1 (en) 2010-03-24
WO1999051266A3 (en) 1999-12-09
EP1067962A2 (en) 2001-01-17
ATE461709T1 (de) 2010-04-15
HUP0102617A2 (hu) 2001-11-28

Similar Documents

Publication Publication Date Title
HUP0102617A3 (en) Derivatives of pneumococcal choline binding proteins for vaccines
EP1113799A4 (en) PROTEIN-BASED PREPARATION
EP1089759A4 (en) SYNTHETIC PEPTIDE VACCINES FOR FOOT AND MOUTH DISEASE
HK1119449A1 (en) Process for obtaining insulin or insulin derivatives having correctly bonded cystine bridges
IL150908A0 (en) Single phase gels and methods for the preparation thereof
HUP0103976A3 (en) Novel methods for therapeutic vaccination
IL135512A0 (en) Method for preparing derivatives of the taxoid class
IL138338A0 (en) Process for the preparation of resin-bound cyclic peptides
EP1150942A4 (en) IMPROVED PROTEIN BINDING COMPOUNDS
HUP0004251A3 (en) Method for preparing bromomethyl-biphenyl derivatives
HUP0003737A3 (en) New process for the preparation of omeprazole
EP0950663A4 (en) USEFUL PROTEIN STABILIZATION AND USEFUL PROTEIN COMPOSITIONS
ZA981885B (en) Method for the preparation of alpha-bromo-lactam derivatives
HUP0203407A3 (en) Process for the preparation of pyrazolopyridazine derivatives
IL140326A0 (en) Protein c derivatives
NO324199B1 (no) Gjodselpreparater med kontrollert frigivelse og fremgangsmate for fremstilling av disse
EP1189632A4 (en) VACCINE FROM A COMBINATION OF PNEUMOCOCCAL SURFACE PROTEINS
ZA981125B (en) Compounds and methods for preparing substituted 4-phenyl-4-cyanocyclohexanoic acids
PL343544A1 (en) Derivatives of pneumococcal choline binding proteins for vaccines
HUP0303579A3 (en) Process for preparing lipid ii and derivatives thereof
GB9823835D0 (en) Component for vaccine
ZA981897B (en) Formualtions for immunological potentiation of vaccines
AU5649299A (en) Protein solution preparation and method for stabilizing the same
GB9930591D0 (en) Component for vaccine
SI1117421T1 (en) Methods for therapeutic vaccination

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees